LEUCOVORIN CALCIUM

LEUCOVORIN CALCIUM was reported 19529 times

LEUCOVORIN CALCIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 32 0.2092
1 ALPHA TUMOUR NECROSIS FACTOR INCREASED 19 0.2043
2 THYMUS HYPOPLASIA 32 0.1839
3 NIPPLE SWELLING 35 0.1394
4 TERATOGENICITY 28 0.0927
5 ANTACID THERAPY 12 0.0923
6 LARYNGEAL DYSPNOEA 20 0.0873
7 CENTRAL NERVOUS SYSTEM LUPUS 18 0.0807
8 CONGENITAL APLASIA 21 0.0675
9 NEUTROPENIA NEONATAL 15 0.0670
10 SLEEP DISORDER THERAPY 13 0.0657
11 NON-CIRRHOTIC PORTAL HYPERTENSION 21 0.0559
12 ANASTOMOTIC COMPLICATION 19 0.0552
13 COLORECTAL CANCER METASTATIC 130 0.0548
14 ESCHERICHIA PYELONEPHRITIS 14 0.0541
15 CONGENITAL HIATUS HERNIA 12 0.0526
16 DISSEMINATED ASPERGILLOSIS 24 0.0508
17 SECONDARY IMMUNODEFICIENCY 55 0.0453
18 OESOPHAGEAL ATRESIA 28 0.0448
19 MYCOBACTERIUM CHELONAE INFECTION 33 0.0447
20 ANTICOAGULANT THERAPY 12 0.0423
21 PORTAL VENOUS GAS 15 0.0413
22 ANALGESIC THERAPY 13 0.0405
23 RECTAL CANCER METASTATIC 14 0.0402
24 INTERLEUKIN LEVEL INCREASED 20 0.0362
25 ABSCESS BACTERIAL 13 0.0358
26 PSEUDOMONAL SEPSIS 62 0.0354
27 SUBRETINAL FLUID 38 0.0348
28 ANASTOMOTIC LEAK 24 0.0346
29 GASTROINTESTINAL STOMA OUTPUT INCREASED 16 0.0341
30 OVERLAP SYNDROME 23 0.0329
31 RECTAL PERFORATION 16 0.0297
32 MINIMAL RESIDUAL DISEASE 14 0.0290
33 KLEBSIELLA TEST POSITIVE 18 0.0276
34 CATHETER RELATED INFECTION 28 0.0276
35 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 21 0.0269
36 COLON CANCER METASTATIC 43 0.0267
37 GRANULOCYTE COUNT DECREASED 49 0.0264
38 MALIGNANT ASCITES 20 0.0261
39 FOETAL DISORDER 20 0.0239
40 DRUG CLEARANCE DECREASED 31 0.0237
41 DIFFUSE ALVEOLAR DAMAGE 27 0.0235
42 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 13 0.0216
43 PERITONEAL DISORDER 14 0.0216
44 STENOTROPHOMONAS INFECTION 29 0.0214
45 CATHETER RELATED COMPLICATION 24 0.0213
46 DILATED CARDIOMYOPATHY 21 0.0208
47 HYPOCHROMIC ANAEMIA 21 0.0207
48 BLOOD CULTURE POSITIVE 58 0.0194
49 BUTTERFLY RASH 19 0.0187
50 ARTERIOSPASM CORONARY 74 0.0184
51 AORTIC THROMBOSIS 21 0.0182
52 NIPPLE PAIN 37 0.0182
53 TROPONIN T INCREASED 23 0.0181
54 HYPERPHOSPHATAEMIA 38 0.0177
55 RECTAL TENESMUS 22 0.0177
56 SKIN TOXICITY 98 0.0173
57 MYOPERICARDITIS 13 0.0167
58 HYPERAMMONAEMIC ENCEPHALOPATHY 29 0.0167
59 DEEP VEIN THROMBOSIS POSTOPERATIVE 33 0.0165
60 DERMATITIS ACNEIFORM 100 0.0164
61 CULTURE URINE POSITIVE 23 0.0164
62 GASTROINTESTINAL PERFORATION 68 0.0163
63 VASCULAR ACCESS COMPLICATION 13 0.0160
64 GASTROINTESTINAL STOMA COMPLICATION 25 0.0159
65 SUBCLAVIAN VEIN THROMBOSIS 18 0.0158
66 NEUTROPENIC INFECTION 15 0.0157
67 LOSS OF EMPLOYMENT 47 0.0155
68 TUMOUR NECROSIS 16 0.0151
69 METASTASES TO PERITONEUM 38 0.0150
70 TROPONIN I INCREASED 25 0.0150
71 GASTROINTESTINAL TOXICITY 71 0.0148
72 MUCOSAL INFLAMMATION 381 0.0145
73 LEUKOENCEPHALOPATHY 54 0.0145
74 ENTEROCOLITIS INFECTIOUS 13 0.0141
75 PRINZMETAL ANGINA 14 0.0141
76 JUGULAR VEIN THROMBOSIS 25 0.0140
77 OBSTRUCTION GASTRIC 18 0.0140
78 CEREBRAL TOXOPLASMOSIS 13 0.0139
79 THROMBOCYTOPENIC PURPURA 19 0.0139
80 DRUG TOXICITY 187 0.0137
81 CARCINOEMBRYONIC ANTIGEN INCREASED 26 0.0134
82 PERIPHERAL SENSORY NEUROPATHY 78 0.0133
83 ENTERITIS 85 0.0133
84 PNEUMATOSIS INTESTINALIS 37 0.0130
85 C-REACTIVE PROTEIN 12 0.0129
86 ARRHYTHMIA SUPRAVENTRICULAR 14 0.0128
87 PERIRECTAL ABSCESS 14 0.0126
88 MYELOSUPPRESSION 445 0.0123
89 PELVIC ABSCESS 14 0.0122
90 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 17 0.0121
91 ORAL INTAKE REDUCED 29 0.0120
92 ALANINE AMINOTRANSFERASE ABNORMAL 25 0.0118
93 LARGE INTESTINAL OBSTRUCTION 24 0.0107
94 HAEMATOTOXICITY 102 0.0107
95 PERIPHERAL MOTOR NEUROPATHY 15 0.0107
96 NEUROPATHY 18 0.0106
97 TUMOUR LYSIS SYNDROME 93 0.0106
98 ASPARTATE AMINOTRANSFERASE ABNORMAL 16 0.0105
99 BONE EROSION 37 0.0105
100 STOMA SITE HAEMORRHAGE 16 0.0104
101 PORTAL HYPERTENSION 32 0.0104
102 FEBRILE BONE MARROW APLASIA 44 0.0103
103 PERIPHERAL SENSORIMOTOR NEUROPATHY 13 0.0103
104 HYPOALBUMINAEMIA 80 0.0103
105 APLASIA 20 0.0102
106 ADENOCARCINOMA OF COLON 19 0.0101
107 NEUROTOXICITY 177 0.0101
108 ENTEROCOLITIS 58 0.0100
109 LARYNGOSPASM 27 0.0100
110 NEOPLASM RECURRENCE 34 0.0100
111 ESCHERICHIA TEST POSITIVE 12 0.0100
112 FEBRILE NEUTROPENIA 661 0.0100
113 METASTASES TO LIVER 175 0.0099
114 INTESTINAL DILATATION 13 0.0097
115 CYTOMEGALOVIRUS CHORIORETINITIS 19 0.0097
116 SMALL INTESTINAL OBSTRUCTION 119 0.0097
117 LUPUS NEPHRITIS 18 0.0096
118 SMALL INTESTINAL PERFORATION 18 0.0096
119 NEUTROPHIL COUNT ABNORMAL 27 0.0095
120 STOMA SITE PAIN 14 0.0095
121 CLOSTRIDIAL INFECTION 32 0.0095
122 OPTIC NEUROPATHY 20 0.0094
123 POLYNEUROPATHY 113 0.0094
124 PLEURITIC PAIN 26 0.0094
125 NEUTROPENIC SEPSIS 67 0.0094
126 GASTROINTESTINAL WALL THICKENING 14 0.0093
127 PARONYCHIA 41 0.0093
128 PARAINFLUENZAE VIRUS INFECTION 14 0.0092
129 GASTRIC PERFORATION 25 0.0092
130 METASTASES TO LUNG 105 0.0091
131 CYTOMEGALOVIRUS VIRAEMIA 40 0.0090
132 LARGE INTESTINE POLYP 62 0.0089
133 RECTAL ABSCESS 15 0.0089
134 PULMONARY INFARCTION 21 0.0089
135 LARGE INTESTINE PERFORATION 61 0.0088
136 NEUTROPENIC COLITIS 18 0.0087
137 TENOSYNOVITIS 24 0.0087
138 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 20 0.0087
139 SUBILEUS 18 0.0086
140 FAILURE TO THRIVE 44 0.0085
141 THERAPY PARTIAL RESPONDER 132 0.0085
142 LIVER ABSCESS 27 0.0083
143 NEUTROPENIA 1131 0.0083
144 HYPOMAGNESAEMIA 115 0.0083
145 CHOLANGITIS 51 0.0082
146 ABDOMINAL ABSCESS 36 0.0081
147 NEUTROPHIL COUNT DECREASED 330 0.0081
148 FACET JOINT SYNDROME 26 0.0080
149 ILEUS 99 0.0080
150 ADHESION 12 0.0079
151 BILE DUCT OBSTRUCTION 15 0.0079
152 VENOUS THROMBOSIS 31 0.0079
153 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 26 0.0078
154 PERIPHERAL VENOUS DISEASE 32 0.0078
155 CHANGE OF BOWEL HABIT 16 0.0078
156 BLOOD LACTIC ACID INCREASED 41 0.0078
157 GENE MUTATION 15 0.0076
158 COMPUTERISED TOMOGRAM ABNORMAL 17 0.0075
159 RECTAL CANCER 23 0.0075
160 OSTEOLYSIS 15 0.0073
161 HYPERAMMONAEMIA 36 0.0072
162 PROCTITIS 20 0.0071
163 ABDOMINAL INFECTION 18 0.0070
164 PNEUMOPERITONEUM 13 0.0070
165 CYTOKINE RELEASE SYNDROME 141 0.0070
166 HEPATIC CYTOLYSIS 88 0.0069
167 EMBOLISM 57 0.0069
168 INTESTINAL PERFORATION 77 0.0069
169 BLOOD ALBUMIN DECREASED 54 0.0068
170 ESCHERICHIA BACTERAEMIA 16 0.0068
171 LYMPHOPENIA 96 0.0068
172 DISEASE PROGRESSION 798 0.0067
173 LEUKOPENIA 335 0.0067
174 VENOOCCLUSIVE LIVER DISEASE 33 0.0067
175 METASTASES TO MENINGES 15 0.0066
176 BACTERIAL INFECTION 123 0.0066
177 HYPERURICAEMIA 27 0.0066
178 ANOREXIA 84 0.0065
179 HAEMOLYTIC URAEMIC SYNDROME 15 0.0065
180 LUNG CONSOLIDATION 18 0.0064
181 HYPOKALAEMIA 294 0.0064
182 NEUROPATHY PERIPHERAL 603 0.0063
183 BLOOD BICARBONATE DECREASED 12 0.0063
184 ELECTROCARDIOGRAM T WAVE INVERSION 14 0.0063
185 RESPIRATORY SYMPTOM 18 0.0063
186 BRONCHOPULMONARY ASPERGILLOSIS 49 0.0063
187 CLOSTRIDIUM DIFFICILE COLITIS 67 0.0063
188 CARDIOTOXICITY 56 0.0063
189 OESOPHAGEAL CANDIDIASIS 25 0.0063
190 OESOPHAGITIS 68 0.0062
191 HYPOPHOSPHATAEMIA 46 0.0062
192 ENTEROCOCCAL INFECTION 30 0.0062
193 DYSAESTHESIA 19 0.0062
194 SUSPECTED OFF LABEL USE 28 0.0062
195 HYPOVOLAEMIA 36 0.0061
196 DENGUE FEVER 14 0.0061
197 HYPOCALCAEMIA 113 0.0060
198 VARICES OESOPHAGEAL 18 0.0059
199 KLEBSIELLA INFECTION 30 0.0059
200 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 30 0.0059
201 CLOSTRIDIUM TEST POSITIVE 13 0.0059
202 ACIDOSIS 45 0.0059
203 TYPE IV HYPERSENSITIVITY REACTION 16 0.0058
204 POLYP 38 0.0058
205 ADENOCARCINOMA 13 0.0058
206 ATELECTASIS 56 0.0058
207 ASCITES 170 0.0058
208 METASTASES TO LYMPH NODES 39 0.0058
209 THROMBOCYTOPENIA 644 0.0058
210 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
211 HYDRONEPHROSIS 43 0.0057
212 BACTERAEMIA 68 0.0057
213 TROPONIN INCREASED 43 0.0056
214 WOUND DEHISCENCE 19 0.0056
215 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 131 0.0056
216 PORTAL VEIN THROMBOSIS 18 0.0056
217 HEPATIC LESION 24 0.0055
218 LUNG INFILTRATION 49 0.0055
219 DUODENAL ULCER 39 0.0055
220 GASTROINTESTINAL NECROSIS 16 0.0055
221 CANDIDIASIS 22 0.0055
222 MYOPIA 13 0.0055
223 PROCTALGIA 35 0.0054
224 BLOOD CREATININE DECREASED 17 0.0054
225 HEPATIC STEATOSIS 101 0.0054
226 STOMATITIS 328 0.0054
227 SUDDEN DEATH 57 0.0054
228 AGRANULOCYTOSIS 100 0.0054
229 MOUTH ULCERATION 111 0.0053
230 INTERSTITIAL LUNG DISEASE 255 0.0053
231 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 31 0.0052
232 LEFT VENTRICULAR DYSFUNCTION 35 0.0052
233 PROTEIN URINE PRESENT 26 0.0052
234 HYPERBILIRUBINAEMIA 54 0.0052
235 NEOPLASM PROGRESSION 179 0.0051
236 HYPOPHAGIA 131 0.0051
237 NECROTISING FASCIITIS 18 0.0051
238 METASTATIC NEOPLASM 22 0.0051
239 THERAPEUTIC AGENT TOXICITY 17 0.0051
240 ORGANISING PNEUMONIA 25 0.0050
241 SPLENOMEGALY 59 0.0050
242 HYPERTRIGLYCERIDAEMIA 29 0.0049
243 PULMONARY EMBOLISM 470 0.0049
244 SECOND PRIMARY MALIGNANCY 41 0.0049
245 ELECTROLYTE IMBALANCE 57 0.0049
246 INTESTINAL ISCHAEMIA 27 0.0049
247 CEREBRAL ISCHAEMIA 25 0.0049
248 DUODENAL ULCER PERFORATION 36 0.0048
249 TYPE I HYPERSENSITIVITY 17 0.0048
250 MALNUTRITION 53 0.0047
251 PERFORMANCE STATUS DECREASED 22 0.0047
252 FOLLICULITIS 49 0.0047
253 BRONCHOPNEUMONIA 16 0.0047
254 CACHEXIA 24 0.0047
255 BLOOD CHLORIDE DECREASED 12 0.0046
256 SEPSIS 519 0.0046
257 ANAL HAEMORRHAGE 13 0.0046
258 LEUKOCYTOSIS 84 0.0046
259 DISSEMINATED INTRAVASCULAR COAGULATION 65 0.0046
260 LOWER GASTROINTESTINAL HAEMORRHAGE 34 0.0046
261 MYOCARDIAL ISCHAEMIA 52 0.0046
262 GUILLAIN-BARRE SYNDROME 22 0.0045
263 JAUNDICE CHOLESTATIC 16 0.0045
264 PROTHROMBIN TIME PROLONGED 27 0.0045
265 DEHYDRATION 602 0.0045
266 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 43 0.0045
267 ILEUS PARALYTIC 20 0.0045
268 BLOOD BILIRUBIN INCREASED 121 0.0045
269 BONE MARROW FAILURE 91 0.0045
270 MULTI-ORGAN FAILURE 77 0.0044
271 PANCYTOPENIA 248 0.0044
272 COLITIS 168 0.0044
273 HEPATOTOXICITY 98 0.0044
274 RASH PUSTULAR 32 0.0044
275 BLOOD PHOSPHORUS DECREASED 16 0.0044
276 NEPHROTIC SYNDROME 30 0.0044
277 ANAPHYLACTOID REACTION 18 0.0044
278 STAPHYLOCOCCAL BACTERAEMIA 19 0.0044
279 SINUS TACHYCARDIA 62 0.0044
280 NORMOCHROMIC NORMOCYTIC ANAEMIA 13 0.0043
281 HYPERTHERMIA 33 0.0043
282 PROTEINURIA 82 0.0043
283 NECROSIS 24 0.0043
284 BACTERIAL SEPSIS 14 0.0043
285 DIFFUSE LARGE B-CELL LYMPHOMA 33 0.0043
286 RASH MACULO-PAPULAR 95 0.0043
287 SEPTIC SHOCK 185 0.0042
288 HYPERNATRAEMIA 21 0.0042
289 PULSE ABSENT 20 0.0042
290 HICCUPS 34 0.0041
291 PHARYNGOLARYNGEAL PAIN 22 0.0041
292 ESCHERICHIA INFECTION 34 0.0041
293 SWOLLEN JOINT COUNT INCREASED 13 0.0041
294 METASTASIS 29 0.0041
295 OLIGURIA 25 0.0040
296 HYPONATRAEMIA 225 0.0040
297 CIRCULATORY COLLAPSE 68 0.0040
298 BLOOD SODIUM DECREASED 75 0.0040
299 THROMBOTIC THROMBOCYTOPENIC PURPURA 14 0.0040
300 RALES 23 0.0040
301 STRESS CARDIOMYOPATHY 23 0.0040
302 INTESTINAL OBSTRUCTION 149 0.0039
303 FIBRIN D DIMER INCREASED 14 0.0039
304 ACUTE GRAFT VERSUS HOST DISEASE 18 0.0039
305 ACUTE PULMONARY OEDEMA 22 0.0039
306 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
307 OESOPHAGEAL ULCER 15 0.0039
308 C-REACTIVE PROTEIN INCREASED 141 0.0039
309 COLITIS ISCHAEMIC 26 0.0039
310 DEEP VEIN THROMBOSIS 250 0.0038
311 PURPURA 34 0.0038
312 FLANK PAIN 36 0.0038
313 REFUSAL OF TREATMENT BY PATIENT 25 0.0038
314 HAEMATOCRIT DECREASED 75 0.0038
315 HYPOVOLAEMIC SHOCK 18 0.0038
316 PULMONARY FIBROSIS 72 0.0037
317 LUNG NEOPLASM 16 0.0037
318 C-REACTIVE PROTEIN ABNORMAL 24 0.0037
319 LEFT VENTRICULAR HYPERTROPHY 16 0.0037
320 BLOOD CREATININE INCREASED 244 0.0037
321 BEHAVIOUR DISORDER 20 0.0037
322 ODYNOPHAGIA 22 0.0037
323 INTERCEPTED MEDICATION ERROR 17 0.0037
324 NEPHROPATHY TOXIC 41 0.0036
325 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 30 0.0036
326 BLOOD URIC ACID INCREASED 21 0.0036
327 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 62 0.0036
328 RED BLOOD CELL SEDIMENTATION RATE INCREASED 40 0.0036
329 FLUID INTAKE REDUCED 18 0.0036
330 RENAL FAILURE ACUTE 152 0.0036
331 ANAL FISTULA 19 0.0036
332 HYPOXIA 125 0.0035
333 BURSITIS 43 0.0035
334 VASCULAR DEVICE INFECTION 16 0.0035
335 LOW BIRTH WEIGHT BABY 28 0.0035
336 BLEPHAROSPASM 22 0.0035
337 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
338 ISCHAEMIC STROKE 62 0.0035
339 COVID-19 PNEUMONIA 41 0.0035
340 HAEMOLYTIC ANAEMIA 31 0.0035
341 STAPHYLOCOCCAL SEPSIS 17 0.0034
342 CHOLECYSTITIS 41 0.0034
343 VASCULITIS 40 0.0034
344 DIVERTICULUM INTESTINAL 15 0.0034
345 PERITONITIS 71 0.0034
346 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 88 0.0034
347 METASTASES TO CENTRAL NERVOUS SYSTEM 44 0.0034
348 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
349 AORTIC DISSECTION 14 0.0034
350 ENCEPHALOPATHY 83 0.0034
351 RHEUMATIC FEVER 15 0.0034
352 ANAL FISSURE 18 0.0034
353 MALIGNANT NEOPLASM PROGRESSION 343 0.0033
354 BLOOD ALKALINE PHOSPHATASE INCREASED 83 0.0033
355 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0033
356 CARDIOPULMONARY FAILURE 13 0.0033
357 GASTROENTERITIS 48 0.0033
358 ANAEMIA 626 0.0033
359 FOOD INTOLERANCE 12 0.0033
360 INFUSION RELATED REACTION 216 0.0033
361 PULMONARY TOXICITY 23 0.0032
362 BREATH SOUNDS ABNORMAL 16 0.0032
363 VENTRICULAR FIBRILLATION 36 0.0032
364 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
365 POLYARTHRITIS 17 0.0032
366 WHITE BLOOD CELL COUNT DECREASED 349 0.0032
367 HAEMOGLOBIN DECREASED 330 0.0032
368 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 23 0.0032
369 BLOOD IRON DECREASED 38 0.0032
370 WOUND INFECTION 35 0.0032
371 EXTRAVASATION 13 0.0032
372 BLOOD CREATINE INCREASED 14 0.0032
373 TACHYPNOEA 43 0.0032
374 GRANULOCYTOPENIA 18 0.0032
375 RESPIRATORY RATE INCREASED 28 0.0032
376 LIVER DISORDER 139 0.0031
377 HAND DEFORMITY 41 0.0031
378 PHLEBITIS 16 0.0031
379 NEUTROPHIL COUNT INCREASED 32 0.0031
380 PLEURAL EFFUSION 190 0.0031
381 HAEMOGLOBIN ABNORMAL 20 0.0031
382 TACHYCARDIA 276 0.0031
383 BLOOD UREA INCREASED 52 0.0031
384 FINGER DEFORMITY 15 0.0031
385 BLOOD POTASSIUM DECREASED 93 0.0031
386 ASPARTATE AMINOTRANSFERASE INCREASED 164 0.0031
387 LIP DRY 28 0.0031
388 HERPES SIMPLEX 20 0.0031
389 SHOCK HAEMORRHAGIC 25 0.0031
390 HAEMOGLOBIN INCREASED 14 0.0031
391 DEVICE RELATED INFECTION 47 0.0031
392 ALANINE AMINOTRANSFERASE INCREASED 187 0.0030
393 ENCEPHALITIS 21 0.0030
394 MUSCLE INJURY 25 0.0030
395 CEREBRAL ATROPHY 12 0.0030
396 CHOLECYSTITIS ACUTE 17 0.0030
397 PYREXIA 1037 0.0030
398 ULCER 47 0.0030
399 ABDOMINAL PAIN 686 0.0029
400 GRAND MAL CONVULSION 27 0.0029
401 HELICOBACTER INFECTION 30 0.0029
402 LIVER INJURY 71 0.0029
403 PANCREATITIS ACUTE 65 0.0029
404 BODY TEMPERATURE INCREASED 59 0.0029
405 THROMBOTIC MICROANGIOPATHY 28 0.0029
406 AUTOIMMUNE DISORDER 28 0.0029
407 RESPIRATORY SYNCYTIAL VIRUS INFECTION 25 0.0029
408 RESPIRATORY FAILURE 209 0.0029
409 PARTIAL SEIZURES 15 0.0029
410 STAPHYLOCOCCAL INFECTION 94 0.0028
411 DIARRHOEA 1833 0.0028
412 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
413 PLATELET COUNT DECREASED 299 0.0028
414 ELECTROCARDIOGRAM ABNORMAL 22 0.0028
415 ACUTE KIDNEY INJURY 429 0.0028
416 GASTRITIS EROSIVE 13 0.0028
417 CORONARY ARTERY STENOSIS 14 0.0028
418 PNEUMOTHORAX 44 0.0028
419 CONTRAINDICATED PRODUCT ADMINISTERED 84 0.0028
420 EJECTION FRACTION DECREASED 43 0.0028
421 DYSARTHRIA 104 0.0028
422 HYDROCEPHALUS 15 0.0028
423 MITRAL VALVE INCOMPETENCE 31 0.0027
424 HYPERTRANSAMINASAEMIA 19 0.0027
425 CARDIOGENIC SHOCK 39 0.0027
426 TEMPERATURE INTOLERANCE 28 0.0027
427 APHTHOUS ULCER 21 0.0027
428 ATAXIA 32 0.0027
429 APLASTIC ANAEMIA 14 0.0027
430 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
431 ASPIRATION 29 0.0026
432 COAGULOPATHY 44 0.0026
433 THERAPEUTIC PRODUCT EFFECT DECREASED 118 0.0026
434 MYELODYSPLASTIC SYNDROME 38 0.0026
435 BUNDLE BRANCH BLOCK RIGHT 12 0.0026
436 CYTOPENIA 32 0.0026
437 TRANSAMINASES INCREASED 58 0.0026
438 HYPERGLYCAEMIA 95 0.0026
439 CHOLESTASIS 50 0.0026
440 JAUNDICE 70 0.0026
441 DERMATITIS EXFOLIATIVE 13 0.0026
442 ASPERGILLUS INFECTION 17 0.0026
443 HYPERCHOLESTEROLAEMIA 25 0.0026
444 DIARRHOEA HAEMORRHAGIC 24 0.0026
445 WHITE BLOOD CELL COUNT INCREASED 98 0.0026
446 SYNOVITIS 46 0.0025
447 HEPATOMEGALY 25 0.0025
448 BODY TEMPERATURE DECREASED 25 0.0025
449 ACUTE CORONARY SYNDROME 21 0.0025
450 PNEUMONITIS 69 0.0025
451 STREPTOCOCCAL INFECTION 14 0.0025
452 RECTAL HAEMORRHAGE 108 0.0025
453 CARDIO-RESPIRATORY ARREST 105 0.0025
454 BLOOD CALCIUM INCREASED 22 0.0025
455 GRAFT VERSUS HOST DISEASE 18 0.0025
456 METABOLIC ACIDOSIS 80 0.0025
457 PETECHIAE 26 0.0025
458 CHILLS 292 0.0025
459 LYMPHOCYTE COUNT DECREASED 44 0.0025
460 GAMMA-GLUTAMYLTRANSFERASE INCREASED 55 0.0025
461 VOMITING 1165 0.0025
462 PERONEAL NERVE PALSY 14 0.0025
463 NEPHROPATHY 23 0.0025
464 CONCUSSION 19 0.0025
465 POST PROCEDURAL COMPLICATION 47 0.0024
466 VIRAL INFECTION 81 0.0024
467 HEMIPARESIS 41 0.0024
468 OXYGEN SATURATION DECREASED 135 0.0024
469 GENERAL PHYSICAL HEALTH DETERIORATION 277 0.0024
470 HAEMODIALYSIS 20 0.0024
471 DRUG INTOLERANCE 230 0.0024
472 POSTOPERATIVE WOUND INFECTION 16 0.0024
473 GASTRIC ULCER 45 0.0024
474 ORAL PAIN 53 0.0024
475 RHINITIS 19 0.0024
476 DISEASE RECURRENCE 112 0.0024
477 WHITE BLOOD CELL COUNT ABNORMAL 15 0.0023
478 BLOOD MAGNESIUM DECREASED 20 0.0023
479 LUNG DISORDER 113 0.0023
480 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
481 TENDERNESS 24 0.0023
482 PSORIATIC ARTHROPATHY 93 0.0023
483 NEUTROPHILIA 13 0.0023
484 TOXIC SKIN ERUPTION 23 0.0023
485 ORAL CANDIDIASIS 30 0.0023
486 CORONAVIRUS INFECTION 15 0.0023
487 TRICUSPID VALVE INCOMPETENCE 18 0.0023
488 CONJUNCTIVITIS 42 0.0023
489 GENERALISED OEDEMA 28 0.0023
490 PERICARDITIS 38 0.0023
491 RHEUMATOID FACTOR POSITIVE 13 0.0022
492 HAEMATEMESIS 57 0.0022
493 HYPERKALAEMIA 78 0.0022
494 PSEUDOMONAS INFECTION 19 0.0022
495 COLON CANCER 33 0.0022
496 HYPOTENSION 444 0.0022
497 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
498 HEPATIC FAILURE 66 0.0022
499 PRESCRIBED OVERDOSE 42 0.0022
500 UROSEPSIS 20 0.0022
501 HYPERTENSION 458 0.0022
502 PEMPHIGUS 27 0.0022
503 FOETAL GROWTH RESTRICTION 13 0.0021
504 MENTAL STATUS CHANGES 59 0.0021
505 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60 0.0021
506 MYOSITIS 19 0.0021
507 HEPATIC FUNCTION ABNORMAL 79 0.0021
508 INFECTION 305 0.0021
509 MYASTHENIA GRAVIS 17 0.0021
510 HAEMODYNAMIC INSTABILITY 16 0.0021
511 SCOLIOSIS 13 0.0021
512 ANGINA PECTORIS 60 0.0021
513 JOINT RANGE OF MOTION DECREASED 28 0.0021
514 EXERCISE TOLERANCE DECREASED 12 0.0021
515 ACUTE RESPIRATORY FAILURE 40 0.0021
516 SCIATICA 33 0.0021
517 GASTROINTESTINAL HAEMORRHAGE 173 0.0021
518 SINUS BRADYCARDIA 20 0.0021
519 HYPOKINESIA 30 0.0021
520 RESPIRATORY DISTRESS 57 0.0021
521 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 145 0.0020
522 BRONCHOSPASM 29 0.0020
523 LOWER LIMB FRACTURE 39 0.0020
524 NEURALGIA 49 0.0020
525 INFLAMMATION 104 0.0020
526 UNRESPONSIVE TO STIMULI 52 0.0020
527 HYPERLIPIDAEMIA 24 0.0020
528 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 13 0.0020
529 ACUTE MYOCARDIAL INFARCTION 59 0.0020
530 MELAENA 44 0.0020
531 ACUTE MYELOID LEUKAEMIA 31 0.0020
532 GASTROINTESTINAL DISORDER 178 0.0020
533 PYELONEPHRITIS 17 0.0020
534 PNEUMONIA BACTERIAL 18 0.0020
535 FISTULA 22 0.0020
536 LYMPHADENOPATHY 69 0.0019
537 DRUG-INDUCED LIVER INJURY 61 0.0019
538 HAEMOLYSIS 15 0.0019
539 PERSONALITY CHANGE 18 0.0019
540 DRUG LEVEL INCREASED 32 0.0019
541 HIATUS HERNIA 25 0.0019
542 APNOEA 15 0.0019
543 CYTOMEGALOVIRUS INFECTION 32 0.0019
544 CEREBRAL INFARCTION 47 0.0019
545 DEVICE OCCLUSION 27 0.0019
546 MOUTH HAEMORRHAGE 14 0.0019
547 CELLULITIS 96 0.0019
548 GASTRITIS 50 0.0019
549 BRAIN OEDEMA 24 0.0019
550 RENAL FAILURE 252 0.0019
551 GASTROINTESTINAL INFECTION 17 0.0019
552 ORTHOSTATIC HYPOTENSION 33 0.0019
553 INCONTINENCE 20 0.0019
554 PANCREATITIS 100 0.0019
555 CLOSTRIDIUM DIFFICILE INFECTION 41 0.0019
556 BLOOD PRESSURE FLUCTUATION 45 0.0019
557 CARDIOMEGALY 23 0.0019
558 BLOOD CALCIUM DECREASED 21 0.0019
559 RHEUMATOID ARTHRITIS 211 0.0019
560 ASTHENIA 694 0.0018
561 ATRIAL FIBRILLATION 179 0.0018
562 CARDIOMYOPATHY 27 0.0018
563 GASTRIC HAEMORRHAGE 21 0.0018
564 NAUSEA 1441 0.0018
565 APPENDICITIS 17 0.0018
566 DENTAL CARIES 20 0.0018
567 SQUAMOUS CELL CARCINOMA 17 0.0018
568 NO THERAPEUTIC RESPONSE 22 0.0018
569 CARDIAC FAILURE ACUTE 12 0.0018
570 FUNGAL INFECTION 60 0.0018
571 URINARY RETENTION 60 0.0018
572 IMPAIRED HEALING 59 0.0018
573 HAEMORRHOIDS 35 0.0018
574 HAEMORRHAGIC STROKE 14 0.0018
575 OSTEOARTHRITIS 76 0.0018
576 HYPERCALCAEMIA 22 0.0018
577 SYSTEMIC LUPUS ERYTHEMATOSUS 63 0.0018
578 ANAPHYLACTIC REACTION 98 0.0018
579 DECREASED APPETITE 411 0.0018
580 MOTOR DYSFUNCTION 18 0.0018
581 IMPAIRED GASTRIC EMPTYING 24 0.0018
582 ABSCESS 28 0.0018
583 ATRIAL FLUTTER 14 0.0018
584 PREMATURE BABY 52 0.0017
585 MUSCULOSKELETAL STIFFNESS 151 0.0017
586 HEPATIC ENCEPHALOPATHY 16 0.0017
587 DEFAECATION URGENCY 12 0.0017
588 EOSINOPHILIA 30 0.0017
589 LACERATION 16 0.0017
590 HAEMATURIA 58 0.0017
591 PHARYNGITIS 21 0.0017
592 DYSPHAGIA 160 0.0017
593 HYPERSENSITIVITY 312 0.0017
594 SUBDURAL HAEMATOMA 24 0.0017
595 LIVE BIRTH 14 0.0017
596 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
597 SUBARACHNOID HAEMORRHAGE 17 0.0017
598 ABDOMINAL PAIN LOWER 42 0.0017
599 OEDEMA PERIPHERAL 202 0.0017
600 CYANOSIS 26 0.0017
601 HEPATIC ENZYME INCREASED 112 0.0016
602 VENTRICULAR TACHYCARDIA 27 0.0016
603 RENAL TUBULAR NECROSIS 16 0.0016
604 APHASIA 49 0.0016
605 HOSPICE CARE 16 0.0016
606 SENSORY LOSS 13 0.0016
607 GINGIVAL BLEEDING 22 0.0016
608 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
609 DYSURIA 59 0.0016
610 URINE OUTPUT DECREASED 14 0.0016
611 TRANSIENT ISCHAEMIC ATTACK 54 0.0016
612 NAIL DISORDER 14 0.0016
613 DECUBITUS ULCER 13 0.0016
614 ARTERIOSCLEROSIS 15 0.0016
615 DEPRESSED LEVEL OF CONSCIOUSNESS 63 0.0016
616 EPISTAXIS 119 0.0016
617 EMPHYSEMA 16 0.0016
618 HAEMOPTYSIS 44 0.0016
619 RESPIRATORY DEPRESSION 19 0.0015
620 BLOOD PRESSURE DECREASED 103 0.0015
621 POOR VENOUS ACCESS 16 0.0015
622 POST PROCEDURAL HAEMORRHAGE 18 0.0015
623 IRRITABLE BOWEL SYNDROME 33 0.0015
624 RESPIRATORY TRACT INFECTION 40 0.0015
625 FLUSHING 156 0.0015
626 BLOOD URINE PRESENT 29 0.0015
627 METASTASES TO BONE 25 0.0015
628 FIBROMYALGIA 37 0.0015
629 SYNCOPE 152 0.0015
630 PHOTOSENSITIVITY REACTION 25 0.0015
631 DYSPNOEA EXERTIONAL 57 0.0015
632 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
633 CHEST PAIN 280 0.0015
634 CYSTITIS 48 0.0015
635 OBESITY 24 0.0015
636 EPILEPSY 46 0.0015
637 GOUT 27 0.0015
638 MASS 21 0.0015
639 PULMONARY OEDEMA 67 0.0015
640 BLOOD TEST ABNORMAL 21 0.0015
641 CHOLELITHIASIS 49 0.0015
642 THERAPY NON-RESPONDER 67 0.0015
643 HEPATIC CIRRHOSIS 28 0.0015
644 SHOCK 34 0.0015
645 ABDOMINAL DISTENSION 154 0.0015
646 PARAESTHESIA 232 0.0015
647 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
648 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
649 COMA 70 0.0015
650 GAIT INABILITY 49 0.0015
651 GASTRIC CANCER 37 0.0015
652 HYPOAESTHESIA ORAL 22 0.0015
653 PNEUMONIA 468 0.0014
654 PULMONARY HYPERTENSION 30 0.0014
655 HYPERTENSIVE CRISIS 16 0.0014
656 CONVULSION 82 0.0014
657 HAEMATOCHEZIA 79 0.0014
658 SKIN ULCER 37 0.0014
659 SKIN INFECTION 16 0.0014
660 CARDIAC FAILURE 114 0.0014
661 URINARY INCONTINENCE 42 0.0014
662 JOINT SWELLING 171 0.0014
663 FACIAL PARALYSIS 12 0.0014
664 LIVER FUNCTION TEST INCREASED 30 0.0014
665 NIGHT SWEATS 45 0.0014
666 ANAPHYLACTIC SHOCK 36 0.0014
667 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
668 OEDEMA 75 0.0014
669 TOXIC EPIDERMAL NECROLYSIS 21 0.0014
670 EYELID PTOSIS 14 0.0014
671 LACTIC ACIDOSIS 44 0.0014
672 HYPERHIDROSIS 174 0.0013
673 SKIN REACTION 19 0.0013
674 VENTRICULAR EXTRASYSTOLES 14 0.0013
675 BASAL CELL CARCINOMA 21 0.0013
676 HAEMORRHAGE INTRACRANIAL 20 0.0013
677 DISORIENTATION 53 0.0013
678 OSTEOPOROSIS 55 0.0013
679 CONFUSIONAL STATE 216 0.0013
680 TRANSFUSION 14 0.0013
681 ANAL INCONTINENCE 12 0.0013
682 ROTATOR CUFF SYNDROME 17 0.0013
683 PALLOR 36 0.0013
684 CONDITION AGGRAVATED 401 0.0013
685 MICTURITION URGENCY 15 0.0013
686 HAEMATOMA 34 0.0013
687 NODULE 17 0.0013
688 DRUG ERUPTION 23 0.0013
689 PERICARDIAL EFFUSION 30 0.0013
690 DELIRIUM 45 0.0013
691 JOINT STIFFNESS 34 0.0013
692 GLOSSODYNIA 29 0.0013
693 BLOOD POTASSIUM INCREASED 21 0.0013
694 BACK INJURY 14 0.0013
695 ERYTHEMA MULTIFORME 12 0.0013
696 DYSPNOEA 727 0.0013
697 HALLUCINATION, VISUAL 27 0.0013
698 URINARY TRACT INFECTION 217 0.0013
699 PRODUCT USE IN UNAPPROVED INDICATION 315 0.0013
700 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
701 DIVERTICULITIS 35 0.0013
702 MUSCULOSKELETAL PAIN 66 0.0013
703 PREMATURE DELIVERY 20 0.0013
704 THROMBOSIS 101 0.0013
705 CANDIDA INFECTION 21 0.0012
706 WEIGHT FLUCTUATION 13 0.0012
707 CARDIAC ARREST 102 0.0012
708 PLATELET COUNT INCREASED 16 0.0012
709 RED BLOOD CELL COUNT DECREASED 35 0.0012
710 MYOCARDITIS 14 0.0012
711 ABDOMINAL PAIN UPPER 251 0.0012
712 PSYCHOTIC DISORDER 36 0.0012
713 LETHARGY 70 0.0012
714 TREATMENT FAILURE 100 0.0012
715 DRUG RESISTANCE 31 0.0012
716 SPEECH DISORDER 63 0.0012
717 DIPLOPIA 31 0.0012
718 RHINORRHOEA 77 0.0012
719 HYPOTHYROIDISM 38 0.0012
720 HYPOAESTHESIA 178 0.0012
721 ARTHROPATHY 66 0.0012
722 MUSCLE ATROPHY 15 0.0012
723 LOWER RESPIRATORY TRACT INFECTION 53 0.0012
724 FATIGUE 906 0.0012
725 TENDONITIS 18 0.0012
726 ERYTHEMA 237 0.0012
727 STATUS EPILEPTICUS 13 0.0011
728 FULL BLOOD COUNT ABNORMAL 12 0.0011
729 HEPATITIS 29 0.0011
730 CARDIAC FAILURE CONGESTIVE 91 0.0011
731 NEOPLASM 13 0.0011
732 ARTHRALGIA 470 0.0011
733 MUSCULAR WEAKNESS 128 0.0011
734 OFF LABEL USE 985 0.0011
735 JOINT INJURY 24 0.0011
736 DRUG INTERACTION 178 0.0011
737 SECRETION DISCHARGE 14 0.0011
738 MATERNAL EXPOSURE DURING PREGNANCY 99 0.0011
739 BACK PAIN 258 0.0011
740 PARAESTHESIA ORAL 16 0.0011
741 GASTROENTERITIS VIRAL 20 0.0011
742 WEIGHT DECREASED 308 0.0011
743 ABDOMINAL DISCOMFORT 185 0.0011
744 ROAD TRAFFIC ACCIDENT 46 0.0011
745 COUGH 308 0.0011
746 ACUTE HEPATIC FAILURE 15 0.0011
747 DERMATITIS 23 0.0011
748 BLOOD PRESSURE INCREASED 167 0.0011
749 EAR INFECTION 29 0.0011
750 RASH 473 0.0011
751 TASTE DISORDER 22 0.0011
752 RETCHING 23 0.0011
753 ORAL HERPES 21 0.0011
754 SKIN FISSURES 21 0.0011
755 DRY MOUTH 87 0.0011
756 COLORECTAL CANCER 51 0.0011
757 FACE OEDEMA 18 0.0011
758 HAEMORRHAGE 111 0.0011
759 CONSTIPATION 231 0.0011
760 CORONARY ARTERY DISEASE 32 0.0011
761 LOSS OF CONSCIOUSNESS 133 0.0010
762 NECK PAIN 58 0.0010
763 THROAT TIGHTNESS 28 0.0010
764 LOCALISED INFECTION 25 0.0010
765 EAR PAIN 20 0.0010
766 CHEST DISCOMFORT 105 0.0010
767 RASH ERYTHEMATOUS 49 0.0010
768 SKIN LESION 28 0.0010
769 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
770 TOXICITY TO VARIOUS AGENTS 170 0.0010
771 INTENTIONAL PRODUCT USE ISSUE 88 0.0010
772 RENAL IMPAIRMENT 84 0.0010
773 LIVER FUNCTION TEST ABNORMAL 29 0.0010
774 HEART RATE DECREASED 35 0.0010
775 TOOTH DISORDER 22 0.0010
776 DIALYSIS 14 0.0010
777 OROPHARYNGEAL PAIN 91 0.0010
778 CEREBRAL HAEMORRHAGE 35 0.0010
779 PRODUCT USE ISSUE 183 0.0010
780 LYMPHOMA 15 0.0010
781 LIMB DISCOMFORT 30 0.0010
782 LUNG INFECTION 15 0.0010
783 COLD SWEAT 17 0.0010
784 BRADYCARDIA 51 0.0010
785 PNEUMONIA ASPIRATION 24 0.0010
786 COVID-19 168 0.0010
787 CATARACT 57 0.0010
788 CORONARY ARTERY OCCLUSION 13 0.0009
789 PRESYNCOPE 23 0.0009
790 RASH MACULAR 33 0.0009
791 EMOTIONAL DISORDER 29 0.0009
792 PULMONARY MASS 14 0.0009
793 IMMUNODEFICIENCY 14 0.0009
794 SINUSITIS 96 0.0009
795 END STAGE RENAL DISEASE 17 0.0009
796 NEOPLASM MALIGNANT 62 0.0009
797 FOETAL EXPOSURE DURING PREGNANCY 75 0.0009
798 FAECES DISCOLOURED 20 0.0009
799 BRONCHITIS 68 0.0009
800 MUSCLE TWITCHING 21 0.0009
801 PARALYSIS 13 0.0009
802 BLOOD CHOLESTEROL INCREASED 42 0.0009
803 FREQUENT BOWEL MOVEMENTS 24 0.0009
804 FEEDING DISORDER 18 0.0009
805 OSTEONECROSIS 29 0.0009
806 ERUCTATION 17 0.0009
807 SENSORY DISTURBANCE 14 0.0009
808 LIP SWELLING 29 0.0009
809 DISCOMFORT 53 0.0009
810 HEART RATE INCREASED 86 0.0009
811 COORDINATION ABNORMAL 12 0.0009
812 WOUND 24 0.0009
813 TREMOR 142 0.0009
814 BLISTER 48 0.0009
815 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 41 0.0009
816 PAIN 522 0.0008
817 SEIZURE 97 0.0008
818 RESPIRATORY DISORDER 25 0.0008
819 NERVOUS SYSTEM DISORDER 26 0.0008
820 DIABETIC KETOACIDOSIS 20 0.0008
821 FALL 276 0.0008
822 CARDIOVASCULAR DISORDER 21 0.0008
823 STEVENS-JOHNSON SYNDROME 18 0.0008
824 SKIN DISORDER 27 0.0008
825 KNEE ARTHROPLASTY 17 0.0008
826 DYSPEPSIA 79 0.0008
827 SWOLLEN TONGUE 25 0.0008
828 DIABETES MELLITUS 61 0.0008
829 FEELING HOT 49 0.0008
830 PREGNANCY 16 0.0008
831 MALAISE 349 0.0008
832 MUSCULOSKELETAL DISORDER 15 0.0008
833 VISION BLURRED 108 0.0008
834 VISUAL ACUITY REDUCED 26 0.0008
835 RASH PRURITIC 42 0.0008
836 ABASIA 19 0.0008
837 CONTUSION 74 0.0008
838 ALOPECIA 150 0.0008
839 RESPIRATORY ARREST 21 0.0008
840 SWELLING 71 0.0008
841 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
842 CHROMATURIA 17 0.0008
843 SWELLING FACE 49 0.0008
844 DYSPHONIA 44 0.0008
845 ARTHRITIS 59 0.0007
846 ECZEMA 39 0.0007
847 LOCAL SWELLING 13 0.0007
848 MYOCARDIAL INFARCTION 130 0.0007
849 PALPITATIONS 87 0.0007
850 TYPE 2 DIABETES MELLITUS 25 0.0007
851 HYPOGLYCAEMIA 36 0.0007
852 DRY EYE 37 0.0007
853 ILL-DEFINED DISORDER 45 0.0007
854 PRODUCTIVE COUGH 35 0.0007
855 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
856 HERPES ZOSTER 42 0.0007
857 HEAD INJURY 23 0.0007
858 NEPHROLITHIASIS 33 0.0007
859 ARRHYTHMIA 34 0.0007
860 RASH PAPULAR 16 0.0007
861 DYSKINESIA 29 0.0007
862 FEMUR FRACTURE 22 0.0007
863 HEADACHE 443 0.0007
864 FLATULENCE 40 0.0007
865 THERAPY CESSATION 36 0.0007
866 GAIT DISTURBANCE 134 0.0007
867 SKIN CANCER 15 0.0007
868 PHOTOPHOBIA 13 0.0007
869 PAIN IN EXTREMITY 203 0.0007
870 DRUG EFFECT INCOMPLETE 25 0.0007
871 URTICARIA 115 0.0007
872 THERAPY INTERRUPTED 49 0.0007
873 DYSSTASIA 20 0.0007
874 HIP FRACTURE 22 0.0007
875 PRURITUS 261 0.0007
876 THERAPEUTIC RESPONSE DECREASED 41 0.0007
877 DISTURBANCE IN ATTENTION 36 0.0007
878 NASOPHARYNGITIS 123 0.0007
879 NASAL CONGESTION 39 0.0007
880 PERIPHERAL SWELLING 102 0.0007
881 BONE DISORDER 12 0.0007
882 WHEEZING 39 0.0007
883 EATING DISORDER 14 0.0007
884 ABNORMAL BEHAVIOUR 26 0.0007
885 DIZZINESS 326 0.0007
886 DEAFNESS 17 0.0006
887 BALANCE DISORDER 56 0.0006
888 COGNITIVE DISORDER 30 0.0006
889 AGGRESSION 32 0.0006
890 ANGIOEDEMA 28 0.0006
891 MUSCLE SPASMS 116 0.0006
892 RIB FRACTURE 13 0.0006
893 FEELING JITTERY 12 0.0006
894 LACRIMATION INCREASED 19 0.0006
895 SKIN EXFOLIATION 53 0.0006
896 LIMB INJURY 17 0.0006
897 SOMNOLENCE 126 0.0006
898 VERTIGO 38 0.0006
899 PANCREATIC CARCINOMA 18 0.0006
900 ASTHMA 70 0.0006
901 MENTAL IMPAIRMENT 15 0.0006
902 THROAT IRRITATION 27 0.0006
903 RESTLESSNESS 22 0.0006
904 PAIN IN JAW 17 0.0006
905 MOBILITY DECREASED 43 0.0006
906 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
907 PRODUCT PRESCRIBING ERROR 14 0.0006
908 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
909 SLEEP DISORDER 41 0.0006
910 LABORATORY TEST ABNORMAL 17 0.0006
911 FEELING COLD 16 0.0006
912 CEREBROVASCULAR ACCIDENT 96 0.0006
913 HYPERSOMNIA 16 0.0006
914 DRUG INEFFECTIVE 734 0.0006
915 CARDIAC DISORDER 52 0.0006
916 GASTRIC DISORDER 19 0.0006
917 INFLUENZA LIKE ILLNESS 45 0.0005
918 AGITATION 39 0.0005
919 EXPOSURE DURING PREGNANCY 33 0.0005
920 ANXIETY 151 0.0005
921 VAGINAL HAEMORRHAGE 23 0.0005
922 BONE PAIN 31 0.0005
923 POLLAKIURIA 22 0.0005
924 TINNITUS 24 0.0005
925 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
926 ACNE 39 0.0005
927 DRY SKIN 68 0.0005
928 OCULAR HYPERAEMIA 24 0.0005
929 INFLUENZA 56 0.0005
930 BURNING SENSATION 34 0.0005
931 MEDICATION ERROR 26 0.0005
932 AMNESIA 30 0.0005
933 EYE PAIN 26 0.0005
934 DEVICE DISLOCATION 20 0.0005
935 DEATH 395 0.0005
936 EYE SWELLING 17 0.0005
937 UNDERDOSE 33 0.0005
938 PLASMA CELL MYELOMA 17 0.0004
939 INJECTION SITE PRURITUS 29 0.0004
940 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
941 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
942 BLINDNESS 17 0.0004
943 BLOOD GLUCOSE INCREASED 78 0.0004
944 SURGERY 24 0.0004
945 DRUG EFFECT DECREASED 22 0.0004
946 DYSGEUSIA 30 0.0004
947 NERVOUSNESS 21 0.0004
948 WEIGHT INCREASED 90 0.0004
949 HYPOACUSIS 17 0.0004
950 OVERDOSE 85 0.0004
951 MENTAL DISORDER 17 0.0004
952 ILLNESS 40 0.0004
953 MIGRAINE 37 0.0004
954 EYE PRURITUS 13 0.0004
955 TREATMENT NONCOMPLIANCE 21 0.0004
956 MYALGIA 64 0.0004
957 INJURY 26 0.0004
958 INJECTION SITE REACTION 25 0.0004
959 DEPRESSION 82 0.0004
960 HOT FLUSH 27 0.0004
961 INJECTION SITE SWELLING 27 0.0004
962 INJECTION SITE ERYTHEMA 43 0.0003
963 INSOMNIA 91 0.0003
964 DEPRESSED MOOD 18 0.0003
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
966 INJECTION SITE BRUISING 27 0.0003
967 RHABDOMYOLYSIS 14 0.0003
968 COLITIS ULCERATIVE 15 0.0003
969 EYE IRRITATION 19 0.0003
970 ADVERSE DRUG REACTION 29 0.0003
971 RENAL DISORDER 15 0.0003
972 PSORIASIS 42 0.0003
973 MEMORY IMPAIRMENT 44 0.0003
974 INTENTIONAL PRODUCT MISUSE 28 0.0003
975 VISUAL IMPAIRMENT 39 0.0003
976 ADVERSE EVENT 28 0.0003
977 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
978 IRRITABILITY 17 0.0003
979 HALLUCINATION 21 0.0003
980 UNEVALUABLE EVENT 21 0.0003
981 INJECTION SITE HAEMORRHAGE 22 0.0003
982 FLUID RETENTION 14 0.0003
983 INJECTION SITE PAIN 82 0.0003
984 FEELING ABNORMAL 63 0.0003
985 HOSPITALISATION 39 0.0003
986 PRODUCT DOSE OMISSION ISSUE 70 0.0002
987 DEVICE MALFUNCTION 16 0.0002
988 EMOTIONAL DISTRESS 26 0.0002
989 DEVICE ISSUE 18 0.0002
990 INCORRECT DOSE ADMINISTERED 45 0.0002
991 BREAST CANCER 17 0.0002
992 SUICIDAL IDEATION 15 0.0002
993 DRUG DOSE OMISSION 21 0.0001
994 PRODUCT QUALITY ISSUE 16 0.0001